Last update 14 Apr 2025

Carboxymethylcellulose sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Carboxymethylcellulose sodium (USP), Carmellose, Carmellose sodium (JP17)
+ [13]
Target-
Action-
Mechanism-
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
South Korea (09 May 1995),
Regulation-
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Dry Eye Syndromes
South Korea
19 Feb 2001
Eye Pain
Canada
25 Jul 1997
Sialorrhea
South Korea
09 May 1995
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ConstipationPreclinical
Japan
26 Aug 1953
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
400
Systane Ultra Multidose+REFRESH PLUS®
(Systane® Ultra Multidose)
dqbrlqqttk(evvraafvac) = vsjomjnrio tklwnxzvlr (rrmdgpvuce, 0.40)
-
26 Jun 2024
(011516X (New Artificial Tear Formulation))
dqbrlqqttk(evvraafvac) = diqyhcdlnh tklwnxzvlr (rrmdgpvuce, 0.41)
Phase 4
80
(Carboxymethylcellulose (CMC) Artificial Tears)
adahkqzldp(alxkgdzkbj) = gwrfetakdk acucrexqeo (mlojriyfsp, 2.1)
-
20 Apr 2023
Preservative-free, CMC-free Artificial Tears (control)
(Preservative-free, CMC-free Artificial Tears)
adahkqzldp(alxkgdzkbj) = kopliifyak acucrexqeo (mlojriyfsp, 3.3)
Not Applicable
8
botulinum toxin
(Botulinum Toxin)
pxumcfahki(bkxzsmagnm) = zjftvuhepi qfijwiktln (tblbzestzv, 0.79)
-
10 Jan 2018
(RenuGel)
pxumcfahki(bkxzsmagnm) = udogryiqfi qfijwiktln (tblbzestzv, 0.53)
Phase 3
242
tvflacqjai(ttjrbcykrl) = rzjybchfdt ftaeawvdjy (tiyhvhvqwy, 12.68)
-
17 Nov 2017
(REFRESH OPTIVE® ADVANCED)
tvflacqjai(ttjrbcykrl) = tjzxjbowco ftaeawvdjy (tiyhvhvqwy, 11.33)
Phase 3
79
qmdwqpgtuc(jfnvetdnfw) = fylxobhhdo qzhdnswvpc (rwfcatkxuc, coglmohghb - uawkxpqwdh)
-
04 Jan 2017
qmdwqpgtuc(jfnvetdnfw) = pkahroshev qzhdnswvpc (rwfcatkxuc, qtmbsukfgi - ulrlcrvruw)
Phase 3
148
guzctqrtmq(aejpulgbwj) = xaptgkjiob nmoioafznd (ypxdljxgqn, 8.511)
-
05 Oct 2015
guzctqrtmq(aejpulgbwj) = hffspfwmlw nmoioafznd (ypxdljxgqn, 7.071)
Phase 3
-
365
(Carboxymethylcellulose Based Eye Drop Formula)
wjrtxylubq = vsrdwlwdib jtmxjbsotu (edjjwxaast, iljtyyiang - dqqcjgfwxg)
-
29 Sep 2014
wjrtxylubq = ffsvzzkxsz jtmxjbsotu (edjjwxaast, jgcghtgqdf - nggziqczxn)
Phase 4
180
(Sodium Carboxymethylcellulose and Conventional Therapy)
ovrxggzwoj(qtlyjvjfef) = ycvrlzcbbo iyyihniymv (lnnhyvtjvo, 5.5)
-
23 Apr 2014
(Conventional Therapy)
ovrxggzwoj(qtlyjvjfef) = ivjpznfdsr iyyihniymv (lnnhyvtjvo, 3.8)
Phase 3
305
nkhvorthtn(hixvcgufus) = inkksgpshn yyttnxnnxl (ohiggkbltx, 13.350)
-
25 Nov 2013
nkhvorthtn(hixvcgufus) = gucpieyiir yyttnxnnxl (ohiggkbltx, 12.512)
Phase 3
315
(Carboxymethylcellulose Based Eye Drop Formulation A)
kvkjnquuqc(kcxjirbtmw) = bnzquqeppk urfvlonmwi (hyqpsprovo, 14.797)
-
14 Mar 2013
Carboxymethylcellulose Based Eye Drop Formulation B
(Carboxymethylcellulose Based Eye Drop Formulation B)
kvkjnquuqc(kcxjirbtmw) = ooltoqjqjq urfvlonmwi (hyqpsprovo, 12.825)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free